Feature Channels: Infectious Diseases

Filters close
Newswise:Video Embedded stunningly-detailed-blueprint-revealed-of-viral-genome-replication-machinery
VIDEO
Released: 24-Jan-2023 5:05 PM EST
Stunningly detailed blueprint revealed of viral genome replication machinery
Morgridge Institute for Research

Wisconsin virologists have outlined in atomic detail the intricate RNA replication machines that coronaviruses create inside infected cells, giving rise to potential new strategies to fight disease.

   
Newswise: Say Ahhh! Fruit Bat Gets a Check-up in the Republic of Congo
Released: 24-Jan-2023 4:55 PM EST
Say Ahhh! Fruit Bat Gets a Check-up in the Republic of Congo
Wildlife Conservation Society

The Wildlife Conservation Society (WCS) released an image of scientists taking a swab from a straw-colored fruit bat (Eidolon helvum) to test it for zoonotic diseases such as the Ebola virus.

   
Released: 24-Jan-2023 2:40 PM EST
Save children from common cold with higher physical activity
Springer

Higher physical activity levels associated with reduced respiratory infection such as the common cold susceptibility in children.

Released: 23-Jan-2023 5:05 PM EST
Coordination of COVID-19 Vaccine Clinical Trials Produces a ‘Treasure Trove’ of Data and a Model for the Future
Covid-19 Prevention Network (CoVPN)

The federally funded COVID-19 Prevention Network was instrumental in the rapid development of safe, effective and lifesaving COVID-19 vaccines during earlier phases of the pandemic. This vital work to expedite Phase 3 clinical trials also resulted in a 'treasure trove' of data, thanks to a highly collaborative and harmonized approach that can serve as a national and even international model for major research initiatives while also guiding responses to future public health emergencies.

Newswise: Study Comparing Early Interventions for Sepsis Shows Patients Have Identical Outcomes
Released: 23-Jan-2023 4:05 PM EST
Study Comparing Early Interventions for Sepsis Shows Patients Have Identical Outcomes
Vanderbilt University Medical Center

Sepsis can cause dangerously low blood pressure, which is typically treated with intravenous (IV) fluids and/or a vasopressor, a drug that causes constriction of the blood vessels. Whether treatment of sepsis-induced low pressure should primarily be treated with IV fluids or vasopressors has been debated for decades with no clear answer.

Newswise: Host-Cell Factors Involved in COVID-19 Infections May Augur Improved Treatments
Released: 23-Jan-2023 4:00 PM EST
Host-Cell Factors Involved in COVID-19 Infections May Augur Improved Treatments
University of California San Diego

Researchers at University of California San Diego and UC Riverside have further elucidated the molecular pathway used by the SARS-CoV-2 virus to infect human lung cells, identifying a key host-cell player that may prove a new and enduring therapeutic target for treating COVID-19.

Released: 23-Jan-2023 3:10 PM EST
Covid-19 in pregnant women can damage the placenta and the fetus
Medical University of Vienna (MedUni Wien)

Using prenatal magnetic resonance imaging, a group of MedUni Vienna researchers examined the placentas and foetuses of women who tested positive for SARS-CoV-2 during pregnancy.

Newswise: Wistar Institute HIV Researchers Win Grant to Explore Genetically Engineered Natural Killer Cells as HIV Therapy
Released: 19-Jan-2023 2:35 PM EST
Wistar Institute HIV Researchers Win Grant to Explore Genetically Engineered Natural Killer Cells as HIV Therapy
Wistar Institute

amfAR, The Foundation for AIDS Research, has awarded Luis J. Montaner, D.V.M., D.Phil., in collaboration with Mohamed Abdel-Mohsen, Ph.D., a Target Grant for $397,663 over two years.

Newswise: MedStar Washington Hospital Center Opens Biocontainment Unit to Care for Patients Who Contract Highly Infectious Diseases
Released: 19-Jan-2023 11:00 AM EST
MedStar Washington Hospital Center Opens Biocontainment Unit to Care for Patients Who Contract Highly Infectious Diseases
MedStar Washington Hospital Center

MedStar Washington Hospital Center has opened a new state-of-the-art Biocontainment Unit (BCU) to care for patients who contract highly infectious diseases. Located near the Emergency Room, the new multi-purpose 15-bed unit will be used primarily for observation and flexed for respiratory isolation and further flexed to care for patients with highly contagious conditions, such as Ebola.

Newswise: Plague trackers: Researchers cover thousands of years in a quest to understand the elusive origins of the Black Death
18-Jan-2023 9:00 AM EST
Plague trackers: Researchers cover thousands of years in a quest to understand the elusive origins of the Black Death
McMaster University

Seeking to better understand more about the origins and movement of bubonic plague, in ancient and contemporary times, researchers at McMaster University, University of Sydney and the University of Melbourne, have completed a painstaking granular examination of hundreds of modern and ancient genome sequences, creating the largest analysis of its kind.

   
Newswise: International policy adviser, epidemiologist Dr. Saad Omer selected inaugural dean for UT Southwestern’s O’Donnell School of Public Health
Released: 19-Jan-2023 10:00 AM EST
International policy adviser, epidemiologist Dr. Saad Omer selected inaugural dean for UT Southwestern’s O’Donnell School of Public Health
UT Southwestern Medical Center

Internationally recognized epidemiologist Saad B. Omer, M.B.B.S, Ph.D., who currently directs the Yale Institute for Global Health, has been appointed the inaugural Dean of the Peter O’Donnell Jr. School of Public Health at UT Southwestern Medical Center.

Newswise: UTSW Pharmacologist James Collins receives 2023 TAMEST Edith and Peter O’Donnell Award
Released: 19-Jan-2023 8:05 AM EST
UTSW Pharmacologist James Collins receives 2023 TAMEST Edith and Peter O’Donnell Award
UT Southwestern Medical Center

James Collins III, Ph.D., Associate Professor of Pharmacology at UT Southwestern Medical Center, will receive the 2023 Edith and Peter O’Donnell Award in Biological Sciences from The Academy of Medicine, Engineering and Science of Texas (TAMEST) for broadening understanding of schistosomiasis.

Newswise: Commonly used antiretroviral drugs used to treat HIV and hepatitis B reduce immune cells’ energy production
Released: 18-Jan-2023 7:45 PM EST
Commonly used antiretroviral drugs used to treat HIV and hepatitis B reduce immune cells’ energy production
University of California, Los Angeles (UCLA), Health Sciences

New UCLA-led research suggests that antiretroviral drugs called TAF and TDF directly reduce energy production by mitochondria, structures inside cells that generate the power that cells use to function. Both drugs led to reduced cellular oxygen consumption rates, a measure of the ability of the mitochondria to produce energy, compared with controls.

Released: 18-Jan-2023 7:15 PM EST
COVID-19 symptoms 6 months after onset, role of vaccination for SARS-CoV-2 infection
JAMA - Journal of the American Medical Association

In this study of 1,832 U.S. adults, the risk of reporting symptoms for 28 or more days after COVID-19 onset was significantly higher in participants who were unvaccinated at the time of infection and those who reported moderate or severe acute illness symptoms.

Released: 18-Jan-2023 1:05 PM EST
Sharing vaccine intellectual property with global community could save millions of lives
Binghamton University, State University of New York

If pharmaceutical companies shared their intellectual property rights to vaccines with the global community, millions of lives could be saved in future pandemics, according to a new paper co-authored by faculty at Binghamton University, State University of New York.

Released: 18-Jan-2023 1:00 PM EST
People with HIV Experience Higher Rates of Inflammation and Immune Activity During Pregnancy
Rutgers University-New Brunswick

People with HIV have a higher chance of having chronic systemic inflammation during pregnancy, according to a Rutgers study.

Released: 18-Jan-2023 10:05 AM EST
Vaccination Provides Effective Protection Against Increased Risk of Pregnancy Complications due to COVID-19 Omicron Variant
Ann and Robert H. Lurie Children's Hospital of Chicago

The global network led by the Oxford Maternal and Perinatal Health Institute (OMPHI) at the University of Oxford has published in the journal Lancet the results of the ‘2022 INTERCOVID Study’ conducted in 41 hospitals across 18 countries, including Ann & Robert H. Lurie Children’s Hospital of Chicago.

Released: 17-Jan-2023 7:05 PM EST
Vaccination gets a boost when people know their neighbors are doing it
University of Texas at Austin (UT Austin)

Just as a highly transmissible variant prompts officials to extend COVID-19 emergency status, one of the largest surveys ever conducted shows people are more willing to get vaccinated when health workers reveal how many others are doing so.

   
Newswise: Durable SARS-CoV-2 antibodies bind to two viral targets at once
Released: 17-Jan-2023 4:20 PM EST
Durable SARS-CoV-2 antibodies bind to two viral targets at once
La Jolla Institute for Immunology

A new study led by scientists at La Jolla Institute for Immunology (LJI) shows how ideal antibodies against SARS-CoV-2 hit their marks. Now scientists are looking at how we might harness their power in new antibody therapeutics and even more effective COVID-19 vaccines.

   
Newswise: Increasing Robo4 expression may help with infections
Released: 17-Jan-2023 1:10 PM EST
Increasing Robo4 expression may help with infections
Osaka University

The researchers screened a library of drugs using a mouse endothelial cell line to identify pathways that are involved in the regulation of Robo4 and found that two competitive SMAD signaling pathways appear to regulate Robo4 expression. When the researchers treated LPS-injected mice with a drug that inhibits ALK1-SMAD signaling, they observed increased Robo4 expression, decreased vascular permeability, and reduced mortality.

Released: 17-Jan-2023 12:45 PM EST
Mucosal antibodies in the airways provide durable protection against SARS-CoV-2
Karolinska Institute

High levels of mucosal IgA antibodies in the airways protect against SARS-CoV-2 infection for at least eight months. Omicron infection generates durable mucosal antibodies, reducing the risk of re-infection.

Newswise: Preparing for Coming RSV, Influenza Epidemics
12-Jan-2023 12:00 PM EST
Preparing for Coming RSV, Influenza Epidemics
American Institute of Physics (AIP)

Nonpharmaceutical interventions slowed the spread of COVID-19 and other infectious diseases but now, as NPIs are lifted, countries are seeing a resurgence in several respiratory diseases. In Chaos, scientists, using data from Hong Kong to develop their model, describe a threshold control method that can be used to predict the best time to lift NPIs without overwhelming the hospital systems when these other respiratory diseases inevitably surge back. They found that reintroducing NPI measures when a threshold of 600 severe cases is reached could ensure that the hospital system in Hong Kong is not overwhelmed by severely infected patients.

   
Released: 17-Jan-2023 8:00 AM EST
Improving Adult Immunization Rates the Focus of Partnership Between ATS and Three Health Systems Across the U.S.
American Thoracic Society (ATS)

NEW YORK, NY – Jan. 17, 2023 – The American Thoracic Society is starting the new year poised to improve vaccination rates with three health system partners: University of Arizona/ Banner Health; West Virginia University Hospitals, Inc.; and San Francisco Health Network/ University of California.

Released: 16-Jan-2023 3:45 PM EST
Gone fishing: highly accurate test for common respiratory viruses uses DNA as ‘bait’
University of Cambridge

A new test that ‘fishes’ for multiple respiratory viruses at once using single strands of DNA as ‘bait’, and gives highly accurate results in under an hour, has been developed by Cambridge researchers.

Newswise: When battling multiple infections, infants and toddlers at higher risk of severe outcomes, study suggests
Released: 12-Jan-2023 3:00 PM EST
When battling multiple infections, infants and toddlers at higher risk of severe outcomes, study suggests
Corewell Health

Results of the 18-month study, published in Lancet Regional Health - Americas and led by Amit Bahl, M.D., M.P.H., emergency medicine with Corewell Health East, formerly Beaumont Health, showed that while omicron cases had the highest hospital admission rates among children ages 0 to 17, serious, even deadly, cases of illness were less likely during omicron than during the delta and alpha variants. In fact, the odds of severe disease were 65% lower during omicron compared to alpha.

Newswise: Key Change in Genetics of SARS-CoV-2 Evolved to Counter Weakness Caused by the Virus’ Initial Mutation that Enabled Its Spread
Released: 12-Jan-2023 9:00 AM EST
Key Change in Genetics of SARS-CoV-2 Evolved to Counter Weakness Caused by the Virus’ Initial Mutation that Enabled Its Spread
Johns Hopkins Medicine

Researchers at Johns Hopkins Medicine say their new studies suggest that the first pandemic-accelerating mutation in the SARS-CoV-2 virus, which causes COVID-19, evolved as a way to correct vulnerabilities caused by the mutation that started the SARS-CoV-2 pandemic.

Released: 11-Jan-2023 7:40 PM EST
Annual or biannual boosters are optimal for fighting endemic COVID-19, study shows
Yale School of Public Health

While COVID-19 boosters have been found to protect against infection, hospitalization, and severe illness, the waning of their protection has led to uncertainty about when it is most appropriate to get an additional booster shot.

Released: 11-Jan-2023 11:05 AM EST
Researchers Fix ‘Fundamental Flaw,’ Improving Pandemic Prediction Model
North Carolina State University

Researchers identified and addressed a flaw in a commonly used pandemic model that can cause the model to severely underestimate disease spread.

   
Released: 10-Jan-2023 5:55 PM EST
Perceptions of stress, mood associated with listening to music during COVID-19 lockdown
JAMA - Journal of the American Medical Association

Listening to music in daily life was significantly associated with lower levels of stress during the COVID-19 lockdown period in this study of 711 adults.

Newswise: Paving the way toward a cure? Study reports new insights into role of proteins in HIV latency
Released: 10-Jan-2023 5:50 PM EST
Paving the way toward a cure? Study reports new insights into role of proteins in HIV latency
University of Ottawa

Understanding HIV latency at the molecular level is crucial for efforts to eliminate the viral scourge that causes AIDS.

Newswise: Analysis: A Longer View on COVID-19 Antibodies
Released: 10-Jan-2023 3:00 PM EST
Analysis: A Longer View on COVID-19 Antibodies
Cedars-Sinai

A new analysis by Cedars-Sinai investigators is furthering the scientific community’s understanding of COVID-19 immunity by showing that similar levels of COVID-19 antibodies are reached over an extended period of time in different population groups.

Released: 9-Jan-2023 5:35 PM EST
B.C. sea sponge has COVID-blocking powers
University of British Columbia

UBC researchers have identified three compounds that prevent COVID-19 infection in human cells, derived from natural sources including a B.C. sea sponge.

Released: 9-Jan-2023 4:50 PM EST
COVID-19 vaccine acceptance increased globally in 2022
CUNY Graduate School of Public Health and Health Policy

Global willingness to accept a COVID-19 vaccine increased from 75.2% in 2021 to 79.1% in 2022, according to a new survey of 23 countries that represent more than 60% of the world’s population, published today in Nature Medicine.

Released: 9-Jan-2023 1:20 PM EST
Smallpox has plagued humans since ancient Egyptian times, new evidence confirms
Microbiology Society

Smallpox was once one of humanity’s most devastating diseases, but its origin is shrouded in mystery. For years, scientific estimates of when the smallpox virus first emerged have been at odds with historical records.

Released: 9-Jan-2023 12:50 PM EST
Surge of SARS-CoV-2 Variants in China and USA Further Emphasizes Need for Surveillance, Preparedness, and International Collaborations
Global Virus Network

Christian Bréchot, MD, PhD, President of the Global Virus Network (GVN), Associate Vice President for International Partnerships and Innovation at the University of South Florida and Professor of the Division of Infectious Disease, Department of Internal Medicine at USF Health Morsani College of Medicine, the GVN Southeast U.S. Regional Headquarters today issued a statement on the surge of SARS-CoV-2.

Released: 6-Jan-2023 6:05 PM EST
Tip Sheet: New genetic risk factors identified for colorectal cancer, new challenge trial on a tuberculosis vaccine — and 2022 news highlights
Fred Hutchinson Cancer Center

Below are summaries of recent Fred Hutchinson Cancer Center research findings and other news. Interested in news you may have missed in 2022 from Fred Hutch?

Released: 6-Jan-2023 5:45 PM EST
More than two billion are infected with this disease; Vitamin D can help
University of Copenhagen, Faculty of Health and Medical Sciences

Sarcomas are cancer tumours found in e.g. the bones, muscles or fatty tissue. It is a rare type of cancer seen in only one per cent of cancer patients. It is complex and difficult to treat.

Newswise: New approach to epidemic modeling could speed up pandemic simulations
Released: 5-Jan-2023 6:00 PM EST
New approach to epidemic modeling could speed up pandemic simulations
Santa Fe Institute

Simulations that help determine how a large-scale pandemic will spread can take weeks or even months to run. A recent study in PLOS Computational Biology offers a new approach to epidemic modeling that could drastically speed up the process.

   
Newswise: Effects of highly pathogenic avian influenza on canids investigated
Released: 5-Jan-2023 3:35 PM EST
Effects of highly pathogenic avian influenza on canids investigated
Hokkaido University

Researchers at Hokkaido University have revealed the effects of high pathogenicity avian influenza virus infection on an Ezo red fox and a Japanese raccoon dog, linking their infection to a recorded die-off of crows.

Newswise: NIH launches Home Test to Treat, a pilot COVID-19 telehealth program
Released: 5-Jan-2023 3:00 PM EST
NIH launches Home Test to Treat, a pilot COVID-19 telehealth program
National Institute of Biomedical Imaging and Bioengineering

NIH, in collaboration with the Administration for Strategic Preparedness and Response at HHS, has launched the Home Test to Treat program, an entirely virtual community health intervention that will provide free COVID-19 health services—at-home rapid tests, telehealth sessions and at-home treatments—in selected communities.

   
Newswise: Machine Learning Tackles Long COVID
Released: 5-Jan-2023 11:05 AM EST
Machine Learning Tackles Long COVID
Lawrence Berkeley National Laboratory

There are so many unknowns about long COVID. Why is the range of symptoms so vast? How do pre-existing conditions play a role? Scientists have developed a machine learning tool to accelerate discoveries using actual patient data.

   
Released: 4-Jan-2023 7:40 PM EST
Does COVID change the body’s response to other threats? Depends on your sex
Yale University

The long-term effects of infection on the immune system have long intrigued John Tsang, a Yale immunobiologist. After the body has faced down a pathogen, does the immune system return to the previous baseline? Or does a single infection change it in ways that alter how it will respond not only to a familiar virus but also to the next new viral or bacterial threat it faces?

Released: 4-Jan-2023 4:15 PM EST
Data Analytics Could Prevent Testing Bottlenecks During Future Pandemics
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

Breaking research demonstrates the efficacy of two data analytics-based strategies that clinical labs employed to meet COVID-19 testing demands during the height of the pandemic. These findings, published in the Data Science Issue of AACC’s The Journal of Applied Laboratory Medicine, give labs a blueprint for using data analytics to ensure patient access to testing during future infectious disease outbreaks.

   
Newswise: A Three-Dose Malaria Vaccine Shows Safety, Efficacy in West African Adults
Released: 4-Jan-2023 12:55 PM EST
A Three-Dose Malaria Vaccine Shows Safety, Efficacy in West African Adults
University of Maryland School of Medicine

A three-dose regimen of a whole-parasite vaccine against malaria – called Plasmodium falciparum sporozoite (PfSPZ) vaccine – demonstrated safety and efficacy when tested in adults living in Burkina Faso, West Africa, which has endemic malaria.

Newswise: New role of small RNAs in Salmonella infections uncovered
Released: 3-Jan-2023 4:50 PM EST
New role of small RNAs in Salmonella infections uncovered
Carl R. Woese Institute for Genomic Biology

Salmonella are food-borne pathogens that infect millions of people a year. To do so, these bacteria depend on a complex network of genes and gene products that allow them to sense environmental conditions.

Released: 3-Jan-2023 4:10 PM EST
Examination of COVID-19 vaccine reactions after multisystem inflammatory syndrome in children
JAMA - Journal of the American Medical Association

In this study of study of 385 patients ages 5 or older with a history of multisystem inflammatory syndrome in children (MIS-C), no serious adverse events were reported after COVID-19 vaccination.

Newswise: Geospatial Epidemiologist Joins Rutgers Global Health Institute
Released: 3-Jan-2023 2:10 AM EST
Geospatial Epidemiologist Joins Rutgers Global Health Institute
Rutgers University-New Brunswick

Ubydul Haque, a geospatial epidemiologist who designs data- and technology-driven solutions for confronting global public health problems, has joined Rutgers Global Health Institute.

Newswise: December Research Highlights
Released: 29-Dec-2022 5:45 PM EST
December Research Highlights
Cedars-Sinai

A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.



close
4.49487